Limited antibody response after BA.4‐5 adapted booster vaccination in rheumatic patients receiving anti‐TNF therapy: Results of a case series-Reference-Cited by-同舟云学术

Limited antibody response after BA.4‐5 adapted booster vaccination in rheumatic patients receiving anti‐TNF therapy: Results of a case series

Published:2023-12 Issue:12 Volume:95 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Geisen Ulf M.¹^ORCID,Voß Mathias²,Rose Ruben²,Neumann Franziska³,Bäumler Carina³,Müller Sina³,Paltzow Lea³,Christophersen Christina M.³,Münier Merle³,Hildebrand Elena¹,Hoff Paula⁴,Longardt Ann C.⁵,Lorentz Thomas³,Schirmer Jan H.¹,Sümbül Melike⁶,Tran Florian⁷⁸,Berner Dennis¹,Fickenscher Helmut²,Gerdes Sascha⁶,Schreiber Stefan²⁷⁸,Krumbholz Andi²³^ORCID,Hoyer Bimba F.¹

Affiliation:

1. Medical Department I, Rheumatology, and Clinical Immunology Christian‐Albrecht University of Kiel and University Medical Center Schleswig‐Holstein Campus Kiel Kiel Germany

2. Institute for Infection Medicine Christian‐Albrecht University of Kiel and University Medical Center Schleswig‐Holstein Kiel Germany

3. Labor Dr. Krause und Kollegen MVZ GmbH Kiel Germany

4. Department of Rheumatology Endokrinologikum‐Gruppe Berlin Germany

5. Department of Pediatrics Christian‐Albrecht University of Kiel and University Medical Center Schleswig‐Holstein Campus Kiel Kiel Germany

6. Department for Dermatology Christian‐Albrecht University of Kiel and University Medical Center Schleswig‐Holstein Campus Kiel Kiel Germany

7. Institute of Clinical Molecular Biology Christian‐Albrecht University of Kiel Kiel Germany

8. Department for Internal Medicine I Christian‐Albrecht University of Kiel and University Medical Center Schleswig‐Holstein Campus Kiel

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.29263

Reference12 articles.

1. Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies

2. Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors

3. Rheumatoid Arthritis — Common Origins, Divergent Mechanisms

4. Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

5. The long term vaccine‐induced anti‐SARS‐CoV‐2 immune response is impaired in quantity and quality under TNFα blockade

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti‐TNF therapy impairs both short‐ and long‐term IgG responses after repeated vaccination;Allergy;2024-07-25

2. Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination – kinetics of plasma antibodies, plasmablasts and memory B cells;Frontiers in Immunology;2024-05-14

3. Additional Reassuring Data for SARS-CoV-2 Vaccination in Immune-Mediated Inflammatory Diseases, but With a Catch;The Journal of Rheumatology;2024-02-01